Investing Profile

Edward Van Wezel

InvestorVC
Managing Partner at BGV (BioGeneration Ventures)
Photo of Edward Van Wezel, Managing Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $1M
$500K
6
€250M
CompanyStageDateRound SizeTotal Raised
Confo Therapeutics
Series BJul 2024$65M
Series AMay 2019$34M
$99M
Citryll
Series BJul 2020$21M
$21M
Co-investors: Isabelle de Cremoux (Seventure Partners)
Azafaros
Series AFeb 2020$27M
SeedJul 2018
$27M
Co-investors: Sander Slootweg (Forbion)
Noviogendix Holding
Series UnknownJan 2007